Surrogate study endpoints in the era of cancer immunotherapy
Ann Transl Med
.
2018 Nov;6(Suppl 1):S27.
doi: 10.21037/atm.2018.09.31.
Authors
Tsuyoshi Hamada
1
2
,
Keisuke Kosumi
2
3
,
Yousuke Nakai
1
,
Kazuhiko Koike
1
Affiliations
1
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
2
Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
3
Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan.
PMID:
30613602
PMCID:
PMC6291549
DOI:
10.21037/atm.2018.09.31
No abstract available
Publication types
Editorial
Comment